Use of broad-spectrum antibiotics and the development of irritable bowel syndrome

Wisconsin Medical Journal

Volumn 111, Issue 1, 2012, Pages 17-20

  Villarreal, Armando A ^a   Aberger, Frank J ^a   Benrud, Ryan ^a   Gundrum, Jacob D ^a  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; MACROLIDE; PENICILLIN G; TETRACYCLINE;

ADULT; ANXIETY; BODY MASS; CLINICAL FEATURE; COLON FLORA; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; FEMALE; FIBROMYALGIA; HIGH RISK POPULATION; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PELVIS PAIN SYNDROME; PRESCRIPTION; PREVALENCE; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE;

ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; WISCONSIN;

EID: 84859131881     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ 3rd. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol. 2000:95(10):2816-2824.
2. Schuster MM. Defining and diagnosing irritable bowel syndrome. J Manag Care. 2001;7(Suppl 8):S246-S251.
3. Podovei M, Kuo B. Irritable bowel syndrome: a practical review. South Med Ass. 2006;99(11):1235-1242.
4. Thompson WG. The road to Rome. Gastroenterology. 2006:130:1552-1556.
5. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. Gastroenterology. 2006;6:26-33.
6. Quigley EMM. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. J Dig Dis. 2007;8(1):2-7.
7. Jernberg C, Löfmark S, Edlund C. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology. 2010;156(Pt 11):3216-3223.
8. de la Cochetiere MF, Durand T, Lepage P, Bourreille A, Galmiche JP, Doré J. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol. 2005;43(11):5588-5592.
9. Lode H, von der Höh N, Ziege S, Borner K, Nord CE. Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora. Scan J Infec Dis. 2001;33(12):899-903.
10. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis. 2001;1(2):101-114.
11. Pultz NJ, Stiefel U, Ghannoum M, Helfand MS, Donskey CJ. Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice. Antimicrob Agents Chemother. 2005;49(1):438-440.
12. Acar JF. A comparison of side effects of levofloxacin to other agents concerning the ecological and microbiological effects on normal human flora. Chemotherapy. 2001;47(Suppl 3):15-23.
13. Croswell A, Amir E, Teggatz P, Barman M, Salzman NH. Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect Immun. 2009;77(7):2741-2753.
14. Santelmann H, Howard JM. Yeast metabolic products, yeast antigens and yeast as possible triggers for irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2005;17(1):21-26.
15. Cohen R, Roth FJ, Delgado E, Ahearn DG, Kalser MH. Fungal flora of the normal human small and large intestine. N Eng J Med. 1969;280(12):638-641.
16. Giuliano M, Barza M, Jakobus NV, Gorbach SL. Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemother. 1987;31(2):202-206.
17. Nosal R. Histamine release from isolated rat mast cells due to glycoprotein from Candida albicans in vitro. J Hyg Edpidemiol Microbiol Immunol. 1974;18(3):377-378.